Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway

Endocrinology

Volumn 144, Issue 1, 2003, Pages 306-312

  Mize, Amy L ^a   Shapiro, Robert A ^b,c   Dorsa, Daniel M ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN SUBUNIT;

ARTICLE; CELL LINE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOIDS; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RECEPTORS, ESTROGEN; TRANSFECTION;

EID: 0037233177     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220698     Document Type: Article

References (47)

1. Paganinihill A, Henderson VW 1994 Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140:256-261
2. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J 1994 Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 42:919-922
3. Sherwin BB 1994 Estrogenic effects on memory in women. Ann N Y Acad Sci 743:213-230
4. Birge SJ 1996 Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 44:865-870
5. Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M 1999 Estrogen replacement therapy and cognitive decline in memory-impaired postmenopausal women. Biol Psychiatry 46:182-188
6. Lafferty FW, Fiske ME 1994 Postmenopausal estrogen replacement: A long-term cohort study. Am J Med 97:66-77
7. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH 1996 Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335:453-461
8. Hurn PD, Macrae IM 2000 Estrogen asa neuroprotectant in stroke. J Cereb Blood Flow Metab 20:631-652
9. Bishop J, Simpkins JW 1994 Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 5:303-308
10. Green PS, Bishop J, Simpkins JW 1997 17α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511-515
11. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM 2002 Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J Neurochem 82:674-682
12. Behl C, Widmann M, Trapp T, Holsboer F 1995 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482
13. Singer CA, Rogers KL, Dorsa DM 1998 Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons. Neuroreport 9:2565-2568
14. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL 1992 A new, nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 131:1305-1312
15. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
16. Aronica SM, Kraus WL, Katzenellenbogen BS 1994 Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521
17. Ahmad S, Singh N, Glazer RI 1999 Role of AKT1 in 17β-estra. Biochem Pharmacol 58:425-430
18. Migliaccio A, Di DM, Castoria G, de FA, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
19. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM 1997 Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology 138:4030-4033
20. Singh M, Setalo G, Guan X, Warren M, Toran AC 1999 Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188
21. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM 1999 The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463
22. Rydel RE, Greene LA 1988 cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA 85:1257-1261
23. Maher P, Davis JB 1996 The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16:6394-6401
24. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
25. Kuiper GG, Enmark E, Pelto HM, Nilsson S, Gustafsson J-Å 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
26. Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Geppert TD, Cobb MH 1993 Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 268:5097-5106
27. Robbins DJ, Cobb MH 1992 Extracellular signal-regulated kinases 2 auto-phosphorylates on a subset of peptides phosphorylated in intact cells in response to insulin and nerve growth factor: Analysis by peptide mapping. Mol Biol Cell 3:299-308
28. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ, Sturgill TW 1991 Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10:885-892
29. Kumar V, Green S, Staub A, Chambon P 1986 Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5:2231-2236
30. Greenamyre JT, Penney JB, Young AB, D'Amato CJ, Hicks SP, Shoulson I 1985 Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 227:1496-1499
31. Choi DW 1992 Excitotoxic cell death. J Neurobiol 23:1261-1276
32. Lees GJ 1993 Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54:287-322
33. Olney JW 1969 Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719-721
34. Choi DW 1988 Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634
35. Michaels RL, Rothman SM 1990 Glutamate neurotoxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations. J Neurosci 10:283-292
36. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT 1989 Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558
37. Sugioka K, Shimosegawa Y, Nakano M 1987 Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210:37-39
38. Green PS, Gridley KE, Simpkins JW 1998 Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione. Neuroscience 84:7-10
39. Gollapudi L, Oblinger MM 1999 Stable transfection of PC12 cells with estrogen receptor (ERα): Protective effects of estrogen on cell survival after serum deprivation. J Neurosci Res 56:99-108
40. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM 2001 Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98:1952-1957
41. Kim H, Bang OY, Jung MW, Ha SD, Hong HS, Huh K, Kim SU, Mook-Jung I 2001 Neuroprotective effects of estrogen against β-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci Lett 302:58-62
42. Sawada H, Shimohama S 2000 Neuroprotective effects of estradiol in mesencephalic dopammergic neurons. Neurosci Biobehav Rev 24:143-147
43. Wang L, Andersson S, Warner M, Gustafsson JA 2001 Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA 98:2792-2796
44. Vasudevan N, Kow LM, Pfaff DW 2001 Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc Natl Acad Sci USA 98:12267-12271
45. Linford NJ, Yang Y, Cook DG, Dorsa DM 2001 Neuronal apoptosis resulting from high doses of the isoflavone genistein: Role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 299:67-75
46. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M 2000 The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA 97:3602-3607
47. Kuroki Y, Fukushima K, Kanda Y, Mizuno K, Watanabe Y 2001 Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur J Neurosci 13:472-476